Emergent
OpenMTB-Audit
arxiv
Executive Summary
Exposing over-refusal and clinical expert perspectives in LLM-based molecular tumor board safety evaluation.
Research report not yet generated. Check back soon — our AI generates deep-dive reports for high-scoring trends daily.
Don't just track trends — act on them
Every morning, get one actionable product opportunity with evidence, pricing strategy, and validation path. 14-day free trial.
Start Free Trial →